{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:20:57Z","timestamp":1789503657506,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T00:00:00Z","timestamp":1685059200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T00:00:00Z","timestamp":1685059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003651","name":"Seoul National Hospital","doi-asserted-by":"publisher","award":["0420180530"],"award-info":[{"award-number":["0420180530"]}],"id":[{"id":"10.13039\/501100003651","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    This study aimed to assess the likely association of gut microbiome with low anterior resection syndrome (LARS) symptoms. Postoperative stool samples from patients with minor or major LARS after sphincter-preserving surgery (SPS) for rectal cancer were collected and analyzed using 16S ribosomal RNA sequencing method. The symptom patterns of LARS were classified into two groups (\n                    <jats:italic>PC1LARS, PC2LARS<\/jats:italic>\n                    ) using principal component analysis. The dichotomized sum of questionnaire items (\n                    <jats:italic>sub1LARS, sub2LARS<\/jats:italic>\n                    ) was used to group patients according to the main symptoms. According to microbial diversity, enterotype, and taxa,\n                    <jats:italic>PC1LARS<\/jats:italic>\n                    and\n                    <jats:italic>sub1LARS<\/jats:italic>\n                    were associated with frequency-dominant LARS symptoms and patients, while\n                    <jats:italic>PC2LARS<\/jats:italic>\n                    and\n                    <jats:italic>sub2LARS<\/jats:italic>\n                    were grouped as incontinence-dominant LARS symptoms and patients.\n                    <jats:italic>Butyricicoccus<\/jats:italic>\n                    levels decreased while overall LARS scores increased. The \u03b1-diversity richness index Chao1 showed a significantly negative correlation in\n                    <jats:italic>sub1LARS<\/jats:italic>\n                    and a positive correlation in\n                    <jats:italic>sub2LARS<\/jats:italic>\n                    . In\n                    <jats:italic>sub1LARS<\/jats:italic>\n                    , the severe group showed a lower\n                    <jats:italic>Prevotellaceae<\/jats:italic>\n                    enterotype and higher\n                    <jats:italic>Bacteroidaceae<\/jats:italic>\n                    enterotype than the mild group.\n                    <jats:italic>Subdoligranulum<\/jats:italic>\n                    and\n                    <jats:italic>Flavonifractor<\/jats:italic>\n                    showed a negative and a positive correlation with\n                    <jats:italic>PC1LARS<\/jats:italic>\n                    , respectively, while showing a negative relationship with\n                    <jats:italic>PC2LARS<\/jats:italic>\n                    .\n                    <jats:italic>Lactobacillus<\/jats:italic>\n                    and\n                    <jats:italic>Bifidobacterium<\/jats:italic>\n                    were negatively correlated to\n                    <jats:italic>PC1LARS<\/jats:italic>\n                    . Frequency-dominant LARS had decreased diversity of gut microbiome and showed lower levels of lactic acid-producing bacteria.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-34557-2","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T08:02:07Z","timestamp":1685088127000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Gut microbiome associated with low anterior resection syndrome after rectal cancer surgery"],"prefix":"10.1038","volume":"13","author":[{"given":"Min Jung","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soyoung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Won","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo Jun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Ki","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Bum","family":"Ryoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu Joo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosep","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Yong","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,26]]},"reference":[{"key":"34557_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"34557_CR2","doi-asserted-by":"publisher","first-page":"330","DOI":"10.4143\/crt.2022.128","volume":"54","author":"MJ Kang","year":"2022","unstructured":"Kang, M. J. et al. Cancer statistics in Korea: Incidence, mortality, survival, and prevalence in 2019. Cancer Res. Treat. 54, 330\u2013344 (2022).","journal-title":"Cancer Res. Treat."},{"key":"34557_CR3","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1097\/SLA.0b013e3181ae330e","volume":"250","author":"LK Temple","year":"2009","unstructured":"Temple, L. K. et al. Factors associated with sphincter-preserving surgery for rectal cancer at national comprehensive cancer network centers. Ann. Surg. 250, 260\u2013267 (2009).","journal-title":"Ann. Surg."},{"key":"34557_CR4","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.ejso.2009.11.011","volume":"36","author":"M Kusters","year":"2010","unstructured":"Kusters, M. et al. Patterns of local recurrence in rectal cancer; A study of the Dutch TME trial. Eur. J. Surg. Oncol. 36, 470\u2013476 (2010).","journal-title":"Eur. J. Surg. Oncol."},{"key":"34557_CR5","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S1470-2045(12)70236-X","volume":"13","author":"CLC Bryant","year":"2012","unstructured":"Bryant, C. L. C., Lunniss, P. J., Knowles, C. H., Thaha, M. A. & Chan, C. L. H. Anterior resection syndrome. Lancet Oncol. 13, 403\u2013408 (2012).","journal-title":"Lancet Oncol."},{"key":"34557_CR6","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/bjs5.50312","volume":"4","author":"EHA Pieniowski","year":"2020","unstructured":"Pieniowski, E. H. A. et al. Prevalence of low anterior resection syndrome and impact on quality of life after rectal cancer surgery: Population-based study. BJS Open 4, 935\u2013942 (2020).","journal-title":"BJS Open"},{"key":"34557_CR7","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/DCR.0000000000000116","volume":"57","author":"T Juul","year":"2014","unstructured":"Juul, T. et al. Low anterior resection syndrome and quality of life. Dis. Colon Rectum 57, 585\u2013591 (2014).","journal-title":"Dis. Colon Rectum"},{"key":"34557_CR8","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/DCR.0000000000000552","volume":"59","author":"NJ Battersby","year":"2016","unstructured":"Battersby, N. J. et al. Predicting the risk of bowel-related quality of life impairment after restorative resection for rectal cancer. Dis. Colon Rectum 59, 270\u2013280 (2016).","journal-title":"Dis. Colon Rectum"},{"key":"34557_CR9","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/DCR.0000000000001228","volume":"62","author":"EHA Pieniowski","year":"2019","unstructured":"Pieniowski, E. H. A. et al. Low anterior resection syndrome and quality of life after sphincter sparing rectal cancer surgery. Dis. Colon Rectum 62, 14\u201320 (2019).","journal-title":"Dis. Colon Rectum"},{"key":"34557_CR10","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/codi.15517","volume":"23","author":"P Christensen","year":"2021","unstructured":"Christensen, P. et al. Management guidelines for low anterior resection syndrome\u2014The MANUEL project. Colorectal Dis. 23, 461\u2013475 (2021).","journal-title":"Colorectal Dis."},{"key":"34557_CR11","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1055\/s-0036-1584500","volume":"29","author":"T Ridolfi","year":"2016","unstructured":"Ridolfi, T., Berger, N. & Ludwig, K. Low anterior resection syndrome: Current management and future directions. Clin. Colon Rect. Surg. 29, 239\u2013245 (2016).","journal-title":"Clin. Colon Rect. Surg."},{"key":"34557_CR12","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.ijsu.2018.06.031","volume":"56","author":"AD Croese","year":"2018","unstructured":"Croese, A. D. et al. A meta-analysis of the prevalence of low anterior resection syndrome and systematic review of risk factors. Int. J. Surg. 56, 234\u2013241 (2018).","journal-title":"Int. J. Surg."},{"key":"34557_CR13","first-page":"688","volume":"67","author":"NJ Battersby","year":"2018","unstructured":"Battersby, N. J. et al. Development and external validation of a nomogram and online tool to predict bowel dysfunction following restorative rectal cancer resection: The POLARS score. Gut 67, 688\u2013696 (2018).","journal-title":"Gut"},{"key":"34557_CR14","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1111\/codi.15463","volume":"23","author":"BJ Yoon","year":"2021","unstructured":"Yoon, B. J. et al. Effects of probiotics on bowel function restoration following ileostomy closure in rectal cancer patients: A randomized controlled trial. Colorectal Dis. 23, 901\u2013910 (2021).","journal-title":"Colorectal Dis."},{"key":"34557_CR15","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/j.1445-2197.2012.06082.x","volume":"82","author":"JH Stephens","year":"2012","unstructured":"Stephens, J. H. & Hewett, P. J. Clinical trial assessing VSL#3 for the treatment of anterior resection syndrome. ANZ J. Surg. 82, 420\u2013427 (2012).","journal-title":"ANZ J. Surg."},{"key":"34557_CR16","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.3390\/jcm9072181","volume":"9","author":"IJ Park","year":"2020","unstructured":"Park, I. J. et al. Effects of probiotics on the symptoms and surgical outcomes after anterior resection of colon cancer (POSTCARE): A randomized, double-blind, placebo-controlled trial. J. Clin. Med. 9, 2181 (2020).","journal-title":"J. Clin. Med."},{"key":"34557_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.5056\/jnm20149","volume":"27","author":"R Singh","year":"2021","unstructured":"Singh, R. et al. Gut microbial dysbiosis in the pathogenesis of gastrointestinal dysmotility and metabolic disorders. J. Neurogastroenterol. Motil. 27, 19\u201334 (2021).","journal-title":"J. Neurogastroenterol. Motil."},{"key":"34557_CR18","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.cell.2015.02.047","volume":"161","author":"M Yano Jessica","year":"2015","unstructured":"Yano Jessica, M. et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 161, 264\u2013276 (2015).","journal-title":"Cell"},{"key":"34557_CR19","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/s41586-020-2474-7","volume":"583","author":"PA Muller","year":"2020","unstructured":"Muller, P. A. et al. Microbiota modulate sympathetic neurons via a gut-brain circuit. Nature 583, 441\u2013446 (2020).","journal-title":"Nature"},{"key":"34557_CR20","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/s41586-020-1975-8","volume":"578","author":"Y Obata","year":"2020","unstructured":"Obata, Y. et al. Neuronal programming by microbiota regulates intestinal physiology. Nature 578, 284\u2013289 (2020).","journal-title":"Nature"},{"key":"34557_CR21","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1096\/fj.14-259598","volume":"29","author":"CS Reigstad","year":"2015","unstructured":"Reigstad, C. S. et al. Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells. FASEB J. 29, 1395\u20131403 (2015).","journal-title":"FASEB J."},{"key":"34557_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1365-2982.2011.01803.x","volume":"24","author":"GC Parkes","year":"2012","unstructured":"Parkes, G. C. et al. Distinct microbial populations exist in the mucosa-associated microbiota of sub-groups of irritable bowel syndrome. Neurogastroenterol. Motil. 24, 31\u201339 (2012).","journal-title":"Neurogastroenterol. Motil."},{"key":"34557_CR23","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.cell.2020.10.040","volume":"183","author":"RAT Mars","year":"2020","unstructured":"Mars, R. A. T. et al. Longitudinal multi-omics reveals subset-specific mechanisms underlying irritable bowel syndrome. Cell 183, 1137\u20131140 (2020).","journal-title":"Cell"},{"key":"34557_CR24","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1053\/j.gastro.2011.07.043","volume":"141","author":"M Rajilic-Stojanovic","year":"2011","unstructured":"Rajilic-Stojanovic, M. et al. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 141, 1792\u20131801 (2011).","journal-title":"Gastroenterology"},{"key":"34557_CR25","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1053\/j.gastro.2014.02.009","volume":"146","author":"AD Kostic","year":"2014","unstructured":"Kostic, A. D., Xavier, R. J. & Gevers, D. The microbiome in inflammatory bowel disease: Current status and the future ahead. Gastroenterology 146, 1489\u20131499 (2014).","journal-title":"Gastroenterology"},{"key":"34557_CR26","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1038\/ncomms4114","volume":"5","author":"CM Theriot","year":"2014","unstructured":"Theriot, C. M. et al. Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. Nat. Commun. 5, 3114 (2014).","journal-title":"Nat. Commun."},{"key":"34557_CR27","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nature13828","volume":"517","author":"CG Buffie","year":"2015","unstructured":"Buffie, C. G. et al. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 517, 205\u2013208 (2015).","journal-title":"Nature"},{"key":"34557_CR28","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gks1219","volume":"41","author":"C Quast","year":"2013","unstructured":"Quast, C. et al. The SILVA ribosomal RNA gene database project: Improved data processing and web-based tools. Nucleic Acids Res. 41, D590\u2013D596 (2013).","journal-title":"Nucleic Acids Res."},{"key":"34557_CR29","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan, B. J. et al. DADA2: High-resolution sample inference from Illumina amplicon data. Nat. Methods 13, 581\u2013583 (2016).","journal-title":"Nat. Methods"},{"key":"34557_CR30","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s40168-018-0470-z","volume":"6","author":"NA Bokulich","year":"2018","unstructured":"Bokulich, N. A. et al. Optimizing taxonomic classification of marker-gene amplicon sequences with QIIME 2\u2019s q2-feature-classifier plugin. Microbiome 6, 90 (2018).","journal-title":"Microbiome"},{"key":"34557_CR31","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","volume":"37","author":"E Bolyen","year":"2019","unstructured":"Bolyen, E. et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat. Biotechnol. 37, 852\u2013857 (2019).","journal-title":"Nat. Biotechnol."},{"key":"34557_CR32","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1097\/SLA.0b013e31824f1c21","volume":"255","author":"KJ Emmertsen","year":"2012","unstructured":"Emmertsen, K. J. & Laurberg, S. Low anterior resection syndrome score: development and validation of a symptom-based scoring system for bowel dysfunction after low anterior resection for rectal cancer. Ann. Surg. 255, 922\u2013928 (2012).","journal-title":"Ann. Surg."},{"key":"34557_CR33","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1038\/s41598-021-82149-9","volume":"11","author":"MJ Kim","year":"2021","unstructured":"Kim, M. J. et al. Two dominant patterns of low anterior resection syndrome and their effects on patients\u2019 quality of life. Sci. Rep. 11, 3538 (2021).","journal-title":"Sci. Rep."},{"key":"34557_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061217","volume":"8","author":"PJ McMurdie","year":"2013","unstructured":"McMurdie, P. J. & Holmes, S. phyloseq: An R package for reproducible interactive analysis and graphics of microbiome census data. PLoS ONE 8, e61217 (2013).","journal-title":"PLoS ONE"},{"key":"34557_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1009442","volume":"17","author":"H Mallick","year":"2021","unstructured":"Mallick, H. et al. Multivariable association discovery in population-scale meta-omics studies. PLoS Comput. Biol. 17, e1009442 (2021).","journal-title":"PLoS Comput. Biol."},{"key":"34557_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030126","volume":"7","author":"I Holmes","year":"2012","unstructured":"Holmes, I., Harris, K. & Quince, C. Dirichlet multinomial mixtures: Generative models for microbial metagenomics. PLoS ONE 7, e30126 (2012).","journal-title":"PLoS ONE"},{"key":"34557_CR37","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1053\/j.gastro.2016.09.049","volume":"152","author":"J Tap","year":"2017","unstructured":"Tap, J. et al. Identification of an intestinal microbiota signature associated with severity of irritable bowel syndrome. Gastroenterology 152, 111-123e8 (2017).","journal-title":"Gastroenterology"},{"key":"34557_CR38","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1097\/MCG.0b013e318269fdd5","volume":"46","author":"L Morelli","year":"2012","unstructured":"Morelli, L. & Capurso, L. FAO\/WHO guidelines on probiotics: 10 years later. J. Clin. Gastroenterol. 46, S1\u2013S2 (2012).","journal-title":"J. Clin. Gastroenterol."},{"key":"34557_CR39","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1136\/gutjnl-2015-309618","volume":"65","author":"D Vandeputte","year":"2016","unstructured":"Vandeputte, D. et al. Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut 65, 57\u201362 (2016).","journal-title":"Gut"},{"key":"34557_CR40","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.1007\/s10620-020-06500-2","volume":"66","author":"H Tian","year":"2021","unstructured":"Tian, H. et al. Analysis of gut microbiome and metabolite characteristics in patients with slow transit constipation. Dig. Dis. Sci. 66, 3026\u20133035 (2021).","journal-title":"Dig. Dis. Sci."},{"key":"34557_CR41","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.surg.2008.03.014","volume":"143","author":"WY Lee","year":"2008","unstructured":"Lee, W. Y. et al. Surgical autonomic denervation results in altered colonic motility: An explanation for low anterior resection syndrome?. Surgery 143, 778\u2013783 (2008).","journal-title":"Surgery"},{"key":"34557_CR42","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1093\/bjs\/znab071","volume":"108","author":"SB Ryoo","year":"2021","unstructured":"Ryoo, S. B. et al. Anterior resection syndrome: A randomized clinical trial of a 5-HT3 receptor antagonist (ramosetron) in male patients with rectal cancer. Br. J. Surg. 108, 644\u2013651 (2021).","journal-title":"Br. J. Surg."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34557-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34557-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34557-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T09:09:51Z","timestamp":1685092191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34557-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,26]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["34557"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-34557-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2410538\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,26]]},"assertion":[{"value":"24 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Yosep Ji is the CEO of the HEM Pharma. All other authors have nothing to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8578"}}